Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
Objectives: This review aims to summarize the current literature on recurrent and metastatic (r/m) cervical cancer, especially first-line and second-line immunotherapy. Clinical benefits including efficacy and safety of new therapeutic options are also reviewed. Mechanism: The published relevant art...
Saved in:
Main Authors: | Yuke Wu (Author), Xiang He (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines
by: Aaron Praiss, et al.
Published: (2022) -
Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I)
by: Szu-Ting Yang, et al.
Published: (2024) -
Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer
by: Masafumi Yasunaga, et al.
Published: (2022) -
Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer
by: Sha Sha, et al.
Published: (2024) -
The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
by: Yu J, et al.
Published: (2019)